Honda conducts surprise reusable rocket test, aims spaceflight by 2029
Signage displayed at the Honda Motor Co. headquarters in Tokyo, Japan, Photographer: Kiyoshi Ota/Bloomberg
TOKYO — Honda succeeded in a launch and landing test of its prototype reusable rocket on Tuesday, the Japanese company said in a surprise announcement, marking a milestone towards its 2029 goal of achieving a suborbital spaceflight.
Honda R&D, the research arm of Japan's second-biggest carmaker, successfully landed its 6.3-meter (20.6-foot) experimental reusable launch vehicle after reaching an altitude of 271 meters (889 feet) at its test facility in northern Japan's space town Taiki, according to the company.
While 'no decisions have been made regarding commercialization of these rocket technologies, Honda will continue making progress in the fundamental research with a technology development goal of realizing technological capability to enable a suborbital launch by 2029,' it said in a statement.
Honda in 2021 said it was studying space technologies such as reusable rockets, but it has not previously announced the details of the launch test. A suborbital launch may touch the verge of outer space but does not enter orbit.
Studying launch vehicles 'has the potential to contribute more to people's daily lives by launching satellites with its own rockets, that could lead to various services that are also compatible with other Honda business,' the company added.
Reusable launch vehicles have been the driver of emerging commercial space missions over the past decade, led by SpaceX's Falcon 9, while its U.S. rivals including Blue Origin and companies in China and Europe also have reusable rocket plans.
Tokyo-based startup Innovative Space Carrier last month said it will test-launch a prototype reusable rocket in the United States in December using an American engine.
Honda's rival Toyota, the world's biggest automaker by sales, earlier this year announced an investment by its research arm in Taiki-based rocket maker Interstellar Technologies to support mass production of launch vehicles.
Japan's government has established a multibillion-dollar space venture fund to subsidize private rockets, satellites and other missions, targeting to double its space industry's size to 8 trillion yen (US$55.20 billion) by the early 2030s.
(Reporting by Kantaro Komiya; editing by David Evans)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR
"Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies." The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China) The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in 2024 and an impressive US$ 1.41 Billion by 2029. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders. Advancements in solid-phase peptide synthesis (SPPS) and hybrid approaches have significantly improved efficiency, yield, and cost-effectiveness, fueling adoption in pharmaceutical R&D. The rise of personalized medicine has further expanded the need for custom peptide synthesis, supporting applications in targeted therapies and biomarker research. Emerging trends such as the integration of automation and AI-driven platforms among the instruments is further likely to fuel the market growth in coming years. Browse in-depth TOC on " Peptide Synthesis Market" 513 - Tables 55 - Figures 460 - Pages Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reagents, dyes & fluorescent labeling reagents, deprotection agents, cleavage reagents, and other reagents. In 2023, the resins segment accounted for the largest share of the peptide synthesis market. Resins play an important role in solid-phase peptide synthesis (SPPS), the most widely used method for peptide production. For instance, polystyrene-based and PEG-based resins are extensively used due to their high stability and scalability. The instruments segment is further divided into peptide synthesizers, chromatography equipment, lyophilizers, and others. The peptide synthesizer segment is further divided into automated and manual peptide synthesizers. Peptide synthesizers dominated the instruments market due to their ability to automate and streamline peptide production, making them essential for research and industrial applications. The growing demand for custom peptides in drug discovery, diagnostic research, and therapeutic applications has further boosted the adoption of advanced synthesizers. The services segment is further divided into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. The peptide synthesis segment dominated the services segment. The increasing adoption of peptides in emerging fields such as personalized medicine, vaccine development, and epigenetics drives demand for custom synthesis solutions, fostering growth in the segment. Based on technique, the peptide synthesis market is segmented into chemical and biological. The chemical segment is further divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and others. The biological segment is divided into recombinant DNA technology and enzymes. The chemical segment dominated the market in 2023. The solid-phase peptide synthesis (SPPS) segment dominates the peptide synthesis market due to its efficiency, scalability, and widespread adoption in research and commercial applications. The dominance of SPPS is further driven by advancements in automation and reagent technologies, which have significantly reduced synthesis time and enhanced yield. Based on application, the market is divided into therapeutics, diagnostics, and research & development. Therapeutics by indication is further divided into cancer, diabetes, obesity, autoimmune disease, and other disease indications. Therapeutics by molecules is further segmented into peptide-based vaccines, peptide-drug conjugates (PDCs), peptide inhibitors, and other molecules. Therapeutic applications dominated the peptide synthesis market due to the growing demand for peptide-based drugs, which offer targeted and effective treatments with fewer side effects compared to traditional small molecules. The peptide synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment held the largest market share in 2023. The rise of peptide-based drugs and biologics has led to increased investments by pharmaceutical and biotech firms in peptide synthesis technologies, particularly in the production of therapeutic peptides for diseases such as cancer, diabetes, and autoimmune disorders. These factors are fueling the growth of the segment. The market is segmented by region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the peptide synthesis market in 2023, and the Asia Pacific region is likely to grow at a significant CAGR during the forecast period. US-dominated North American peptide synthesis market owing to the presence of strong pharmaceutical and biotechnology companies in the country, advanced research infrastructure, and significant investments in drug discovery and development. The Asia Pacific region is anticipated to grow at a significant CAGR due to growing focus on personalized medicine and peptide-based therapeutics in the region fuels the demand for advanced peptide synthesis technologies. The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China), and Bachem Holding AG (Switzerland), among others. The market players have adopted various organic and inorganic growth strategies, such as the development of advanced products, partnerships, agreements, expansions, and acquisitions to strengthen their position in the peptide synthesis market. Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies. The company offers a wide range of peptide synthesis products and services. The company has adopted different growth strategies, such as deals that include agreements, and acquisitions, to maintain its leading position in the peptide synthesis market. The company's strong customer support and extensive distribution network further solidify the company's leadership position in the market. Merck KGaA is a key player in the peptide synthesis market, leveraging its expertise in life sciences and advanced chemical technologies. The company's Novabiochem product line offers a broad range of high-quality reagents, resins, and building blocks essential for efficient and reliable peptide synthesis. Merck KGaA focuses on innovation supporting advanced techniques such as microwave-assisted synthesis, which significantly improves reaction efficiency and yield. The company's strategic partnerships and increased investments in biopharmaceutical R&D further enhance its competitive edge in the market. Merck's strong geographic presence and adoption of growth strategies further contribute to its dominance in the market. For more information, Inquire Now!
CTV News
5 hours ago
- CTV News
Honda conducts surprise reusable rocket test, aims spaceflight by 2029
Signage displayed at the Honda Motor Co. headquarters in Tokyo, Japan, Photographer: Kiyoshi Ota/Bloomberg TOKYO — Honda succeeded in a launch and landing test of its prototype reusable rocket on Tuesday, the Japanese company said in a surprise announcement, marking a milestone towards its 2029 goal of achieving a suborbital spaceflight. Honda R&D, the research arm of Japan's second-biggest carmaker, successfully landed its 6.3-meter (20.6-foot) experimental reusable launch vehicle after reaching an altitude of 271 meters (889 feet) at its test facility in northern Japan's space town Taiki, according to the company. While 'no decisions have been made regarding commercialization of these rocket technologies, Honda will continue making progress in the fundamental research with a technology development goal of realizing technological capability to enable a suborbital launch by 2029,' it said in a statement. Honda in 2021 said it was studying space technologies such as reusable rockets, but it has not previously announced the details of the launch test. A suborbital launch may touch the verge of outer space but does not enter orbit. Studying launch vehicles 'has the potential to contribute more to people's daily lives by launching satellites with its own rockets, that could lead to various services that are also compatible with other Honda business,' the company added. Reusable launch vehicles have been the driver of emerging commercial space missions over the past decade, led by SpaceX's Falcon 9, while its U.S. rivals including Blue Origin and companies in China and Europe also have reusable rocket plans. Tokyo-based startup Innovative Space Carrier last month said it will test-launch a prototype reusable rocket in the United States in December using an American engine. Honda's rival Toyota, the world's biggest automaker by sales, earlier this year announced an investment by its research arm in Taiki-based rocket maker Interstellar Technologies to support mass production of launch vehicles. Japan's government has established a multibillion-dollar space venture fund to subsidize private rockets, satellites and other missions, targeting to double its space industry's size to 8 trillion yen (US$55.20 billion) by the early 2030s. (Reporting by Kantaro Komiya; editing by David Evans)
National Post
7 hours ago
- National Post
Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms
Article content Funding led by Lightspeed Venture Partners will help Multiplier acquire high-growth firms to improve client experience, growth, and productivity with AI Article content SINGAPORE — Today, Multiplier Holdings, a technology company building AI-native professional services firms, publicly launched with $27.5 million in Seed and Series A funding. The Series A round was led by Lightspeed Venture Partners with participation from Ribbit Capital (led the Seed), EDBI, and SV Angel. Multiplier is helping to overcome the AI adoption hurdle by acquiring specialized professional services firms and integrating custom AI automation to deliver better results for clients, drive efficiency and fuel growth. Article content Globally, the professional services market is valued at over $6 trillion, and is projected to grow significantly in the coming years (e.g., tax advisory services are forecasted to grow at 11.2% CAGR). Tax, accounting, specialized advisory and other high-stakes professional services firms face more demand than they can supply with a declining workforce, alongside high labor costs and legacy technologies. Article content Multiplier acquires ambitious boutique services firms, onboards them to its AI-driven practice management platform, and then iteratively and diligently works with the firms' domain experts to uplevel the client experience and improve the scalability of the business. Article content 'Vertical SaaS might not be the best path to modernize an industry. Building an AI-native professional services platform from the ground up creates the most technological leverage and captures more incentive alignment between domain and technology experts than traditional SaaS,' said Justin Overdorff, Partner at Lightspeed Venture Partners. 'The Multiplier approach—an AI-first software company acquiring existing service firms to compete directly in the services business by using proprietary technology—allows us to elevate the client and staff experience in a radical way. As it scales, Multiplier can become the preferred buyer in these categories by underwriting the largest and most repeatable post-acquisition improvements to the business while ensuring firm owners and staff participate in the upside.' Article content Multiplier partners with the firms it owns to directly embed its technology, iteratively developing new features and offering hands-on technical support as a long-term owner, working alongside the firm's staff to create customized AI-driven solutions to fit the exact needs of each specialized firm. This approach enables Multiplier to build customizable solutions to automate critical but time-consuming tasks and free up time to deliver better outcomes for clients. Article content 'We believe the market will reward players who compete on technology-enabled client service through an integrated platform of people and tech. While our portfolio firms maintain operational independence, we align incentives across all stakeholders—from Multiplier leadership to firm leaders and staff—creating hybrid technology firms with exceptional client service, automation, and quality that traditional firms using off-the-shelf AI solutions simply cannot match,' said Noah Pepper, CEO of Multiplier Holdings and former Stripe executive. Article content The model is working. Within the first eight months since starting their tech build-out, Multiplier's AI-powered platform helped Citrine International Tax multiply cash flows by approximately 2.5 times and eliminate large swaths of highly manual work. A significant portion of this lift was shared back with the staff of the firm in the form of performance bonuses while delivering enhanced service to clients. Article content 'When Noah approached us, we saw Multiplier as a unique opportunity to become part of a technology firm and deliver a truly differentiated level of client service– all while growing the business together,' said Gregory Trotman, founder of Citrine International Tax. 'The Multiplier team immersed themselves in our workflows, built a custom end-to-end technology platform and worked with our staff to streamline everything from client onboarding to billing, resulting in a huge lift in productivity.' Article content Clients are noticing the impact of the technology too: 'Citrine has been a major upgrade compared to prior firms we used. Emily, our advisor at Citrine, is more responsive and easier to work with, and the tools she's using help us gain clarity and confidence about where our return is in the workflow – and rapidly confirm when things have been submitted to the authorities,' said Keith Robinson, an American technology investor and former C-level executive living in London who became a Citrine client in the last year. Article content About Lightspeed Venture Partners Article content Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends in AI, Enterprise, Consumer, Health, and Fintech. Over the past 25 years, the Lightspeed team has backed hundreds of entrepreneurs and helped build more than 500 companies globally including Abridge, Affirm, Anthropic, Cato Networks, Epic Games, Glean, Mistral, Moveworks, Navan, Netskope, Rubrik, Snap, Wiz, and more. Lightspeed and its global team currently manage over $30B in AUM across the Lightspeed platform, with investment professionals and advisors in the U.S., Europe, India, Israel, and Southeast Asia. About Multiplier Holdings Multiplier Holdings scales high-impact professional services firms through the power of AI. Multiplier's unique model entails acquiring professional services firms, like specialized tax and accounting practices, and transforming them into more scalable, profitable businesses by systematically integrating custom AI solutions. Multiplier holds a library of AI and workflow components developed in-house that can be configured to fit the needs of each acquired firm. This allows Multiplier to automate critical, time-consuming tasks to increase firm efficiency and productivity and drive growth, while improving both the customer and employee experience. To learn more, visit Article content Article content
